Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Numidargistat + Epacadostat +/- Pembrolizumab in Advanced Solid Tumors
NCT03361228Phase 2Terminated
- Sponsor
- Incyte
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of numidargistat in solid tumor, sponsored by Incyte. Started Mar 2018; status: terminated.
02
Drugs
numidargistat
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03361228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361228.